Cargando…
11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis
OBJECTIVE: In rheumatoid arthritis, the enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is highly expressed at sites of inflammation, where it converts inactive glucocorticoids (GC) to their active counterparts. In conditions of GC excess it has been shown to be a critical regulator of...
Autores principales: | Hardy, R.S., Fenton, C., Croft, A.P., Naylor, A.J., Begum, R., Desanti, G., Buckley, C.D., Lavery, G., Cooper, M.S., Raza, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066611/ https://www.ncbi.nlm.nih.gov/pubmed/29891135 http://dx.doi.org/10.1016/j.jaut.2018.05.010 |
Ejemplares similares
-
11β‐Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation
por: Hardy, Rowan S, et al.
Publicado: (2016) -
11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation
por: Fenton, Chloe G, et al.
Publicado: (2022) -
TNFα depleting therapy improves fertility and animal welfare in TNFα-driven transgenic models of polyarthritis when administered in their routine breeding
por: Naylor, Amy J., et al.
Publicado: (2017) -
Hydroxysteroid dehydrogenase HSD1L is localised to the pituitary–gonadal axis of primates
por: Bird, A Daniel, et al.
Publicado: (2017) -
Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis
por: Webster, Justine M., et al.
Publicado: (2021)